Mixed lymphocyte reaction-conditioned MSC-derived extracellular vesicles enhance graft survival via miR-638-mediated immunoregulation.

Stem Cells Transl Med · 2025 · PMC12012893 · PMID 40261200

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In vivo experiments showed a trend towards improved graft survival in the Rapa + miR-638-MSC-EV Ctr group (medium survival 14 days) compared to the Rapa + MSC-EV Ctr group (medium survival 11 days), although the difference was not statistically significant ( Supplementary Figure 4D , Supplementary Table 3 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.